Endo chief meets healthcare reform head-on

Anticipating the effects of U.S. healthcare reform, Endo Pharmaceuticals Chief Executive David Holveck says his company is diversifying beyond pain medications into other maladies--and beyond drugs, into diagnostics, devices and health services. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.